Karachi: Abbott Laboratories (Pakistan) Limited has announced that its Board of Directors will convene a virtual meeting on Thursday, August 27, 2026, at 3:30 p.m. to discuss the half-yearly financial accounts for the period ending June 30, 2026.

The company, a key player in the healthcare sector, confirmed the meeting through a formal report dated August 20, 2026. As part of the procedural requirements outlined by the Pakistan Stock Exchange (PSX), Abbott Laboratories has instituted a "Close Period" from August 20 to August 27, 2026. During this interval, the directors, CEO, and executives of the company are prohibited from dealing in the company's shares in any capacity.

According to information available from the Pakistan Stock Exchange (PSX), this measure is in compliance with Clause 5.6.4 of PSX Regulations, which aims to maintain transparency and prevent insider trading during crucial financial disclosures.

Abbott Laboratories is preparing to review its financial performance amidst a challenging market environment. The outcomes of this board meeting will be closely watched by investors and stakeholders, given its potential implications for the company's strategic direction and financial health.